DIorio A, Garramone F, Rossi S, Baiano C, Santangelo G
Front Robot AI. 2025; 12:1371583.
PMID: 40034800
PMC: 11872730.
DOI: 10.3389/frobt.2025.1371583.
Panico F, Fonzo E, Verde A, Lancia S, Trojano L
Neurol Sci. 2025; .
PMID: 40029541
DOI: 10.1007/s10072-025-08061-6.
Sarti P, Varrasi S, Guerrera C, Platania G, Furneri G, Torre V
BMC Psychol. 2025; 13(1):129.
PMID: 39962563
PMC: 11834197.
DOI: 10.1186/s40359-024-02239-x.
Di Tella S, Zinzi P, Anzuino I, Lo Monaco M, Tondinelli A, Magistri M
Soc Cogn Affect Neurosci. 2025; 20(1).
PMID: 39948742
PMC: 11840954.
DOI: 10.1093/scan/nsaf007.
Tagliente S, Minafra B, Aresta S, Santacesaria P, Buccoliero A, Palmirotta C
Front Psychol. 2025; 15():1531688.
PMID: 39850970
PMC: 11754226.
DOI: 10.3389/fpsyg.2024.1531688.
Exploring the role of epileptic focus lateralization on facial emotion recognition in the spectrum of mesial temporal lobe epilepsy.
Iannaccone F, Pizzanelli C, Lorenzini F, Turco F, Milano C, Scarpitta C
Front Syst Neurosci. 2025; 18():1491791.
PMID: 39834657
PMC: 11743968.
DOI: 10.3389/fnsys.2024.1491791.
Neuropsychological tests at the Italian Centers for Cognitive Disorders and Dementias: results from a survey on 450 specialized services.
Vaccaro R, Lorenzini P, Giaquinto F, Matascioli F, Carnevale G, Sciancalepore F
Aging Clin Exp Res. 2024; 37(1):1.
PMID: 39704981
PMC: 11662035.
DOI: 10.1007/s40520-024-02869-6.
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET.
Cappiello A, Cuoco S, De Micco R, Satolli S, Di Biasio F, Markushi T
Neurol Sci. 2024; 46(3):1207-1215.
PMID: 39579261
DOI: 10.1007/s10072-024-07887-w.
Normative study of SATURN: a digital, self-administered, open-source cognitive assessment tool for Italians aged 50-80.
Giaquinto F, Assecondi S, Leccese G, Romano D, Angelelli P
Front Psychol. 2024; 15:1456619.
PMID: 39539307
PMC: 11557479.
DOI: 10.3389/fpsyg.2024.1456619.
Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.
Saibene F, Agliardi C, Salvatore A, Arcuri P, Castagna A, Gobbo S
PLoS One. 2024; 19(10):e0309405.
PMID: 39441873
PMC: 11498734.
DOI: 10.1371/journal.pone.0309405.
No matter how big it is, but how you use it: the importance of demographic adjustment in clinical neuropsychology.
Ilardi C, Menichelli A, Federico G, Salvatore M, Manganotti P
Neurol Sci. 2024; 46(2):1027-1030.
PMID: 39436519
DOI: 10.1007/s10072-024-07831-y.
Behavioral Alterations of Spatial Cognition and Role of the Apolipoprotein E-ε4 in Patients with MCI Due to Alzheimer's Disease: Results from the BDSC-MCI Project.
Cammisuli D, Bellocchio V, Milesi A, Aiello E, Poletti B, Verde F
J Clin Med. 2024; 13(18).
PMID: 39336934
PMC: 11432825.
DOI: 10.3390/jcm13185447.
Effectiveness of Two Models of Telerehabilitation in Improving Recovery from Subacute Upper Limb Disability after Stroke: Robotic vs. Non-Robotic.
Pavan A, Fasano A, Lattanzi S, Cortellini L, Cipollini V, Insalaco S
Brain Sci. 2024; 14(9).
PMID: 39335435
PMC: 11430637.
DOI: 10.3390/brainsci14090941.
The Contribution of Cognitive Control Networks in Word Selection Processing in Parkinson's Disease: Novel Insights from a Functional Connectivity Study.
Di Tella S, De Marco M, Anzuino I, Quaranta D, Baglio F, Silveri M
Brain Sci. 2024; 14(9).
PMID: 39335408
PMC: 11430391.
DOI: 10.3390/brainsci14090913.
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum.
Padovani A, Caratozzolo S, Galli A, Crosani L, Zampini S, Cosseddu M
Neurol Sci. 2024; 46(2):697-704.
PMID: 39313687
PMC: 11772383.
DOI: 10.1007/s10072-024-07775-3.
'Knock down the brain': a nonlinear analysis of electroencephalography to study the effects of sub-concussion in boxers.
De Donato R, Maiorana N, Vergari M, De Sandi A, Naci A, Aglieco G
Eur J Neurol. 2024; 32(1):e16411.
PMID: 39275911
PMC: 11618114.
DOI: 10.1111/ene.16411.
Montreal Cognitive Assessment's auditory items (MoCA-22): Normative data and reliable change indices.
Amitrano N, Lord A, Gonzalez D
Appl Neuropsychol Adult. 2024; :1-8.
PMID: 39207946
PMC: 11869320.
DOI: 10.1080/23279095.2024.2396380.
Human reasoning on social interactions in ecological contexts: insights from the theory of mind brain circuits.
Isernia S, Pirastru A, Rossetto F, Cacciatore D, Cazzoli M, Blasi V
Front Neurosci. 2024; 18:1420122.
PMID: 39176386
PMC: 11339883.
DOI: 10.3389/fnins.2024.1420122.
On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
Ilardi C, Menichelli A, Michelutti M, Cattaruzza T, Federico G, Salvatore M
J Alzheimers Dis. 2024; 101(1):293-308.
PMID: 39150828
PMC: 11492110.
DOI: 10.3233/JAD-240339.
The Montreal cognitive assessment: normative data from a large, population-based sample of Chinese healthy adults and validation for detecting vascular cognitive impairment.
Wei Q, Du B, Liu Y, Cao S, Yin S, Zhang Y
Front Neurosci. 2024; 18:1455129.
PMID: 39145298
PMC: 11322342.
DOI: 10.3389/fnins.2024.1455129.